Dr. Menaka Sarav, MD

Dr. Sarav practices at DaVita Stamford Dialysis in Stamford, Connecticut.

Dr. Sarav's NPI, 1548425168, was assigned on July 23, 2008. Dr. Sarav holds Connecticut license 76569.

Dr. Sarav's primary practice is DaVita Stamford Dialysis, at 30 Commerce Rd, Stamford, CT 06902 in Fairfield County. The practice phone is (203) 358-9969.

Dr. Sarav's primary practice is DaVita Stamford Dialysis in Stamford, Connecticut. Dr. Sarav is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Sarav to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sarav practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Sarav's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Sarav's licenses on file in 2 states: Connecticut and Illinois.

CMS data shows 937 Medicare services from Dr. Sarav across 10 procedure codes in 2024, for 369 Medicare patients. Medicare paid $86,970 for them.

CMS counts 369 Medicare patients who saw Dr. Sarav in 2024. The largest group is 75 to 84, with 136 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 3.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sarav's median patient age at 71, with 38% women.

In 2024, Dr. Sarav wrote 856 Medicare Part D claims for 198 patients. 86% of them were for generic drugs. CMS names the drug for 711 of them, across 21 drugs with 11 or more claims each, at $95,085 in total drug cost. In 2023, CMS named 782 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Sarav for performance year 2024, reported as part of a group. Dr. Sarav accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sarav as offering telehealth.

Dmand AI links 13 papers to Dr. Sarav, published from 2017 to 2025. 2017 was the busiest year, with 4. The most frequent topics are Critical Illness, Dietary Proteins and Nutritional Requirements. Dr. Sarav has published most often in Nutr Clin Pract. Dr. Sarav's most frequent co-authors are Martin Richard Huecker, MD, Ryan T. Hurt, MD and Robert G. Martindale, MD.

CMS Open Payments shows 65 general payments to Dr. Sarav from 22 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 96% of the total. Travere Therapeutics, Inc. paid the most, $429.